Skip to main content
TipRanks
Go Ultimate75% OFF

Biosyent (RX) Stock Statistics & Valuation Metrics

56 Followers

Total Valuation

Biosyent has a market cap or net worth of CAD 201.18M. The enterprise value is CAD 162.82M.

Market Cap
CAD 201.18M
Enterprise Value
CAD 162.82M

Share Statistics

Biosyent has 11,308,835 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
11,308,835
Owned by Insiders
19.22%
Owned by Institutions
0.43%

Financial Efficiency

Biosyent’s return on equity (ROE) is 0.22 and return on invested capital (ROIC) is 19.97%.

Return on Equity (ROE)
0.22
Return on Assets (ROA)
0.18
Return on Invested Capital (ROIC)
19.97%
Return on Capital Employed (ROCE)
0.27
Revenue Per Employee
717.53K
Profits Per Employee
150.20K
Employee Count
60
Asset Turnover
0.87
Inventory Turnover
1.71

Valuation Ratios

The current PE Ratio of Biosyent is 20.22. Biosyent’s PEG ratio is 0.98.

PE Ratio
20.22
PS Ratio
3.61
PB Ratio
4.42
Price to FCF
17.06
Price to Operating Cash Flow
16.76
PEG Ratio
0.98

Income Statement

In the last 12 months, Biosyent had revenue of 43.05M and earned 9.01M in profits. Earnings per share was 0.80.

Revenue
43.05M
Gross Profit
32.11M
Operating Income
11.31M
Pretax Income
12.03M
Net Income
9.01M
EBITDA
12.17M
Earnings Per Share (EPS)
0.80

Cash Flow

In the last 12 months, operating cash flow was 12.09M and capital expenditures -298,646, giving a free cash flow of 11.80M billion.

Operating Cash Flow
12.09M
Free Cash Flow
11.80M
Free Cash Flow per Share
1.04

Dividends & Yields

Biosyent pays an annual dividend of CAD 0.06, resulting in a dividend yield of 1.21%

Dividend Per Share
CAD 0.06
Dividend Yield
1.21%
Payout Ratio
26.92%
Free Cash Flow Yield
5.86%
Earnings Yield
4.87%

Stock Price Statistics

Beta
0.91
52-Week Price Change
63.21%
50-Day Moving Average
16.71
200-Day Moving Average
15.18
Relative Strength Index (RSI)
62.01
Average Volume (3m)
8,254

Important Dates

Biosyent upcoming earnings date is Nov 17, 2026, After Close (Not Confirmed).

Last Earnings Date
Aug 20, 2026
Next Earnings Date
Nov 17, 2026
Ex-Dividend Date
May 29, 2026

Financial Position

Biosyent as a current ratio of 5.51, with Debt / Equity ratio of 2.03%

Current Ratio
5.51
Quick Ratio
4.63
Debt to Market Cap
0.00
Net Debt to EBITDA
-1.60
Interest Coverage Ratio
229.23

Taxes

In the past 12 months, Biosyent has paid 3.02M in taxes.

Income Tax
3.02M
Effective Tax Rate
0.25

Enterprise Valuation

Biosyent EV to EBITDA ratio is 13.17, with an EV/FCF ratio of 16.88.

EV to Sales
3.58
EV to EBITDA
13.17
EV to Free Cash Flow
16.88
EV to Operating Cash Flow
16.47

Balance Sheet

Biosyent has CAD 8.94M in cash and marketable securities with CAD 3.14M in debt, giving a net cash position of CAD 5.80M billion.

Cash & Marketable Securities
CAD 8.94M
Total Debt
CAD 3.14M
Net Cash
CAD 5.80M
Net Cash Per Share
CAD 0.51
Tangible Book Value Per Share
CAD 1.69

Margins

Gross margin is 70.21%, with operating margin of 23.21%, and net profit margin of 17.73%.

Gross Margin
70.21%
Operating Margin
23.21%
Pretax Margin
24.04%
Net Profit Margin
17.73%
EBITDA Margin
27.16%
EBIT Margin
23.63%

Analyst Forecast

The average price target for Biosyent is CAD 18.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target
CAD 18.00
Price Target Upside
1.18% Upside
Analyst Consensus
Moderate Buy
Analyst Count
1
Revenue Growth Forecast
40.91%
EPS Growth Forecast
19.88%

Scores

Smart Score
6
AI Score
86